![]() ![]() Although several small studies have provided preliminary results regarding the use of Solitaire™ stents for saccular aneurysms, , the predictors for unfavourable outcomes (mRS, 2–6) related to Solitaire™ have not been fully elucidated. Recently, 58 suitable patients harbouring 68 aneurysms underwent individualised treatment with a new stent (“Solitaire™ AB”) and the forgoing techniques in our institution. The multiple stents overlapping technique, is also an alternative for the reconstruction of dissecting aneurysms in acute cases, such as SAH, acute posterior circulation stroke or neck pain. The use of stenting alone has also been well applied for tiny and fusiform aneurysms. Compared with balloon-assisted coiling, stent-assisted coiling can provide a “scaffolding” for denser packing, reducing the risks of recurrence and rebleeding. For certain ruptured or unruptured wide-necked aneurysms, the appropriate adjunctive tools are crucial. ![]() SAH was the only predictor for unfavourable outcomes (the modified Rankin Scale score, 2–6) during the mean 19-month (range, 12–27 months) of clinical follow-ups ( p<0.05).Įndovascular coiling has emerged as the first-line treatment option for wide-necked intracranial aneurysms. Compared with the immediate post-treatment angiographic results, the follow-up angiographic imaging (mean, 13 months range, 6–25 months) revealed that stent(s) implantation enhanced the rate of class I occlusion from 34% (23/68) to 93% (63/68). Subarachnoid haemorrhages (SAH, p<0.05) and immediate occlusion grades ( p<0.05) were predictors for overall adverse events by univariate analysis. ![]() The majority (75%, 3/4) of thromboembolic events (thrombus, n = 2 infarction, n = 2) occurred in ruptured lesions, and 2 intraprocedural aneurysm ruptures occurred in the course of coiling when the stent(s) was/were applied within 6 months. All of the adverse events (n = 6) occurred in tiny (n = 1, ≤3 mm) or small (n = 5, >3 to ≤10 mm) aneurysms. The rates of the overall and the treatment-related adverse events were 9% (6/68) and 6% (4/68), respectively, and the recurrent rate was 1% (1/68). The technical success rate of Solitaire™ AB stenting was 100%. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |